Does the addition of radiation to adjuvant chemotherapy improve the survival for early‐stage (tumor size ≤4 cm) small cell neuroendocrine carcinoma of the cervix after surgery? A population‐based study
The addition of radiation to adjuvant chemotherapy did not confer a survival benefit for every patient with early-stage SCNEC, except for those with stage T2a1 disease. Moreover, a scoring system was developed to preliminarily identify patients who might benefit from the addition of radiation.
Authors
- Xilin Yang (ORCID: https://orcid.org/0000-0002-9462-7992)
- Zheng Zeng (ORCID: https://orcid.org/0000-0003-0914-8231)
- Junfang Yan (ORCID: https://orcid.org/0000-0002-0101-5947)
- Fuquan Zhang (ORCID: https://orcid.org/0000-0002-6856-2320)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1002/ijgo.70192
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking Union Medical College Hospital